Skip to content
10-K

Annual Report

Inspire Medical Systems, Inc. INSP

0001609550-25-000011

← back to feed
Filed
Feb 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 3, 2025 29.67M sh
Short Term Investments FY 2024 · Dec 31, 2023 $274.84M
Cash And Equivalents FY 2024 · Dec 31, 2023 $185.54M
Current Liabilities FY 2024 · Dec 31, 2023 $78.11M
Total Liabilities FY 2024 · Dec 31, 2023 $104.3M
Current Assets FY 2024 · Dec 31, 2023 $593.74M
Total Assets FY 2024 · Dec 31, 2023 $676.81M
Shares Diluted FY 2024 · Dec 31, 2022 28.07M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $0
Capex FY 2024 · Dec 31, 2022 $9.1M
Operating Cash Flow FY 2024 · Dec 31, 2022 $11.57M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.60
Eps Basic FY 2024 · Dec 31, 2022 −$1.60
Sga Expense FY 2024 · Dec 31, 2022 $320.69M
Rd Expense FY 2024 · Dec 31, 2022 $68.65M
Net Income FY 2024 · Dec 31, 2022 −$44.88M
Operating Income FY 2024 · Dec 31, 2022 −$47.59M
Gross Profit FY 2024 · Dec 31, 2022 $341.74M
Revenue FY 2024 · Dec 31, 2022 $407.86M
Stockholders Equity FY 2024 · Dec 31, 2021 $229.05M